| CONTENTS |
| Introduction Oral Drug Delivery: the Numbers behind the Business Josef Bossart, PhD, Managing Director Pharmanumbers, LLC |
| Specialised Techniques for Developing ODT Dosage Forms Michelle K. Papp, PhD, Formulation Scientist Gopi Venkatesh, PhD, R&D Director Troy Harmon, MS, MBA, Vice-President Business Development Eurand, Inc |
| Company profile Mayne Pharma International |
| Advances in Solid Dose Oral Drug Delivery Gurvinder Singh Rekhi, PhD, Senior Director, Oral Controlled Release Product Development Elan Drug Technologies |
| The Right Formulation – and how to get there Gita Shankar, PhD, Director of Formulations R&D, Pharmaceutical Sciences SRI International |
| SoluBest‘s Solumer Solubilising Platform: an “all in one” technology Amir Zalcenstein, PhD, MBA, Senior Director, Business Development & Planning SoluBest, Ltd |
| Orally Disintegrating Extended Release (ODT-ER) Dosage Forms Woubalem Birmachu, PhD, Senior Manager of New Technology CIMA Labs, Inc |